|

Mid-afternoon market update: Dow surges 200 points, Grid Dynamics shares spike higher

Toward the end of trading Friday, the Dow traded up 0.57% to 36,331.86 while the NASDAQ rose 0.20% to 15,972.41. The S&P also rose, gaining 0.40% to 4,698.70.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 47,187,250 cases with around 772,310 deaths. India confirmed a total of at least 34,332,400 cases and 459,870 deaths, while Brazil reported over 21,849,130 COVID-19 cases with 608,710 deaths. In total, there were at least 249,461,040 cases of COVID-19 worldwide with more than 5,047,620 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares gained by 1.5% on Friday. Meanwhile, top gainers in the sector included Borr Drilling Limited BORR +17.14% (Get Free Alerts for BORR), up 17% and Select Energy Services, Inc. WTTR +11.15% (Get Free Alerts for WTTR) up 15%.

In trading on Friday, health care shares fell 1.7%.

Top Headline

The US economy added 531,000 jobs in October, above analysts’ expectations of 450,000. The US unemployment rate also dropped to 4.6% in October, notching the lowest level since March 2020.

Equities Trading UP

Mainz Biomed B.V. NASDAQMYNZ shares shot up 120% to $11.00. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.

Shares of Grid Dynamics Holdings, Inc. GDYN +26.24% got a boost, shooting 25% to $36.57 following upbeat Q3 results.

ReWalk Robotics Ltd. RWLK +22.49% shares were also up, gaining 27% to $1.6399 after the company announced its ReBoot device has been granted designation as a Breakthrough Device by the FDA.

Equities Trading DOWN

Deciphera Pharmaceuticals, Inc. DCPH -74.96% shares tumbled 75% to $9.05 after announcing disappointing results from the INTRIGUE Phase 3 study of Qinlock in patients with gastrointestinal stromal tumor (GIST) previously treated with Novartis AG's Gleevec (imatinib). The study did not meet the primary endpoint of improved progression-free survival (PFS) compared with the standard of care Pfizer’s Sutent (sunitinib).

Shares of Evaxion Biotech A/S EVAX -44.6% were down 44% to $7.09 after the company priced 3.43 million ADS offering at $7 per ADS.

Emergent BioSolutions Inc. EBS -42.01% was down, falling 41% to $30.83 after reporting a loss for the third quarter.

Commodities

In commodity news, oil traded up 3.2% to $81.31, while gold traded up 1.2% to $1,815.80.

Silver traded up 1% Friday to $24.15 while copper rose 0.2% to $4.3295.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 rose 0.05%, the Spanish Ibex Index rose 1.01% and the German DAX 30 gained 0.15%. Meanwhile, the London’s FTSE 100 rose 0.33%, French CAC 40 rose 0.76% and Italy’s FTSE MIB rose 1%.

The IHS Markit Eurozone construction PMI climbed to 51.2 in October from 50 in the prior month. France construction PMI climbed to 50.3 from 48.9, while industrial production fell by 1.3% in September.

The IHS Markit Germany construction PMI rose to 47.7 in October from 47.1 in September, while industrial production fell 1.1% in September. Spain's industrial production growth eased to 1.2% year-over-year in September. The Halifax house price index in the UK surged 8.1% from a year ago in October.

Economics

The US economy added 531,000 jobs in October, above analysts’ expectations of 450,000. The US unemployment rate also dropped to 4.6% in October, notching the lowest level since March 2020.

The total number of active U.S. oil rigs rose by 6 to 450 rigs this week, Baker Hughes Inc reported.

Data on consumer credit for September will be released at 3:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

AUD/USD flirts with 0.7000, lowest since early August amid bullish USD

AUD/USD hits a fresh low since early August during the Asian session on Friday and looks vulnerable near 0.7000 after breaking below the 200-day SMA overnight. Against the backdrop of the hawkish Fed, a two-day rally in oil prices revives inflation fears and continues to push US bond yields to multi-year highs. Adding to this, geopolitical risks lift the US Dollar to a two-month high, overshadowing RBA rate hike bets and weighing on the pair.

USD/JPY pulls back from three-week high after failing near 159.00

USD/JPY edges lower during the Asian session on Friday, stalling its recent strong move to a three-week high of 159.00 as Japanese Yen bears turn cautious amid intervention fears. Meanwhile, the US Dollar retains a strong bullish undertone as the Fed's hawkish outlook and oil-driven inflation fears continue to push US bond yields to multi-year peaks. Furthermore, the BoJ's dovish rate hike last week might cap JPY and support spot prices.

Gold treads water below $4,300

Gold grabs some buying attention and advances marginally at the end of the week, partially retracing the weekly decline, although it is still navigating below the key $4,300 mark per troy ounce. The fresh selling bias on the Greenback and the modest decline in US Treasury yields appear to support the humble advance in the precious metal.

Crypto Today: Bitcoin and Ethereum edge lower, XRP extends recovery as macro headwinds weigh

The broader cryptocurrency market is consolidating on Friday, with Bitcoin paring losses slightly above $84,000. Ethereum declines in tandem with BTC. Ripple (XRP), meanwhile, paints a different picture.



Fed vs BoJ: Both hiked. The market only believes one of them – and the chart shows which
The Federal Reserve (Fed) and the Bank of Japan (BoJ) have just done something remarkably similar. Both central banks raised interest rates by 25 basis points (bps) last week, both are confronting inflation risks, and both signal that future decisions will depend on incoming economic data.
Fed vs BoJ: Both hiked. The market only believes one of them – and the chart shows which

The Fed and the BoJ have just done something remarkably similar. Both central banks raised interest rates by 25 bps last week, both are confronting inflation risks, and both signal that future decisions will depend on incoming economic data.